Target intelligence / Profile preview

T cell receptor beta variable 20-1 (TRBV20-1)

Target
TRBV20-1
Molecular classification
Receptor, Immunoglobulin superfamily, Variable region of T cell receptor beta chain
01

Overview

T cell receptor beta variable 20-1 (TRBV20-1) encodes the variable region of the beta chain of the T cell receptor (TCR), a critical component of the immune system. The TCR is a heterodimeric protein complex usually comprising an alpha and a beta chain, both of which are highly variable due to V(D)J recombination, enabling recognition of a vast repertoire of antigens presented by the major histocompatibility complex (MHC) on antigen presenting cells. TRBV20-1 is one of the most commonly used variable gene segments in human T cell populations and is part of the TCR complex on T lymphocytes that mediates antigen-specific recognition, leading to immune cell activation, signaling via the CD3 complex, and downstream pathways including MAPK and NF-κB activation. TRBV20-1 is frequently observed in both normal and malignant T cell repertoires and has been used as a molecular marker to study T cell clonality in cancer and infectious diseases[1][2][3][5].

Other names
TRBV201TCRBV20S1TCRBV2S1V segment translation productTVBT1
02

Biological functions

Antigen recognitionImmune responseSignal transductionAdaptive immunity
03

Disease associations

Cancer (notably T-cell leukemias/lymphomas)InfectionOther immune-related diseases
04

Biomarkers

T cell clonality marker (used for profiling clonal expansions in diseases like T cell leukemia/lymphoma)

Beyond the preview

Go deeper on T cell receptor beta variable 20-1 (TRBV20-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 20-1 (TRBV20-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call